SCHEMBL16857789

SCHEMBL16857789

O=C(O)Oc1cnn(-c2nc3cc(Cl)c(-c4ccccc4)cc3c(=O)[nH]2)c1

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16857812 0.88 EGLN1 (0.49) EGLN1
SCHEMBL16857719 0.86 EGLN1 (0.59) EGLN1
SCHEMBL3026741 0.85 EGLN1 (0.66) EGLN1
SCHEMBL16857786 0.85 EGLN1 (0.57) EGLN1
SCHEMBL16857920 0.85 EGLN1 (0.52) EGLN1
SCHEMBL16857891 0.84 EGLN1 (0.49) EGLN1
SCHEMBL16857706 0.83 EGLN1 (0.42) EGLN1
SCHEMBL16857769 0.83 EGLN1 (0.58) EGLN1
SCHEMBL16857773 0.83 EGLN1 (0.56) EGLN1
SCHEMBL16857870 0.83 EGLN1 (0.51) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396316-B1 QUINAZOLINONES AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-07-01 EP claimed